Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Hormone Replacement Therapy Market Outlook

The global hormone replacement therapy market attained a value of USD 5.50 billion in 2023 and is projected to reach USD 10.00 billion by 2032, growing at a CAGR of 6.9% over the forecast period of 2024-2032.

Global Hormone Replacement Therapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on the product type, the oestrogen replacement therapy segment held the majority of the market share in 2020. Based on the route of administration, the parenteral segment is estimated to be the leading segment, accounting for the majority of the market share, followed by oral and transdermal methods.

Regionally, the market is segmented into North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America was the largest market in 2020, accounting for the majority of the market share.

Properties and Applications 

Hormone replacement therapy (HRT) is a treatment used for replenishing the hormones which are present in low levels in the human body. This therapy is particularly favourable for the patients having a deficiency of growth hormone, women in menopausal transition, and geriatric suffering from hypogonadism. It is available in several forms, such as gels, skin, and mouth patches (transdermal), injections, and implants. It is also considered to be a more efficient treatment in comparison to its alternatives, such as chemical drugs, herbal medicines, and others.

Hormone Replacement Therapy Market By Type Of Disease

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The major product types of the market are:

  • Oestrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others

On the basis of route of administration, the industry can be segmented into:

  • Oral
  • Parenteral
  • Transdermal

Based on the type of diseases, the market is divided into:

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

The EMR report looks into the regional markets like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.

Hormone Replacement Therapy Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis 

A rise in the incidences of hormonal imbalance disorders in the neonatal and geriatric populations is primarily driving the market growth. HRT is effective for the treatment of the symptoms of menopause such as night sweats, hot flashes, vaginal dryness, and sexual function. Additionally, it minimises the risk of cardiovascular diseases, vasomotor symptoms, colorectal cancer, and osteoporosis while improving the quality of life. Furthermore, advancements in technology such as the introduction of transdermal drug delivery and new gel-based formulations, coupled with increased investments in research and development activities by the manufacturers are providing a boost to the market growth. Moreover, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations are further expected to stimulate the demand for hormone replacement therapy during the forecast period.

Competitive Landscape 

The report presents a detailed analysis of the following key players in the global hormone replacement therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Novo Nordisk A/S
  • Abbott Laboratories Inc.
  • Pfizer Inc
  • Allergan
  • Bayer AG
  • Merck & Co., Inc.
  • Viatris Inc.
  • Eli Lilly and Company
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd. (Genentech)
  • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
  • ASCEND Therapeutics US, LLC. (Besins Healthcare)
  • AbbVie Inc.

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Route of Administration
  • Type of Disease
  • End User
  • Distribution Channel
  • Region
Breakup by Product
  • Estrogen & Progesterone Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Transdermal
  • Other
Breakup by Type of Disease
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others
Breakup by End User
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Novo Nordisk A/S
  • Abbott Laboratories Inc.
  • Pfizer Inc
  • Allergan
  • Bayer AG
  • Merck & Co., Inc.
  • Viatris Inc.
  • Eli Lilly and Company
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd. (Genentech)
  • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
  • ASCEND Therapeutics US, LLC. (Besins Healthcare)
  • AbbVie Inc.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

Hormone Replacement Therapy Market Report Snapshots

Hormone Replacement Therapy Market Size

Hormone Replacement Therapy Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

In 2023, the global hormone replacement therapy market attained a value of nearly USD 5.50 billion.

The market is projected to grow at a CAGR of 6.9% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 10.00 billion by 2032.

The major drivers of the industry, such as rise in the incidences of hormonal imbalance disorders, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations, are expected to aid the market growth.

The key market trend guiding the growth of the hormone replacement therapy market includes the introduction of transdermal drug delivery and new gel-based formulations.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share. 

The oestrogen replacement therapy segment is the leading product in the industry.

The route of administration is led by parenteral segment in the industry. 

The significant types of diseases in the industry are menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency, among others.

The major players in the industry are Abbott, Novo Nordisk A/S, Pfizer Inc, and Allergan, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124